vcfirmsdirectory.com

Venture capital · Early to growth stage · Est. 2012

Decheng Capital

Decheng Capital is a life sciences investment firm with offices in Silicon Valley and Shanghai. It backs early-stage life science ventures and growth-stage healthcare companies worldwide.

Menlo Park · ShanghaiRegistered · Menlo Park
New investments · 12 months
Fund vehiclesPublic
8
8 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 26 Oct 2026, 16:50 CETSources: decheng.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Decheng Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Decheng Capital right for your round?

Is Decheng Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
8
8 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P.US private fund · Active · Cayman Islands · $825.3M gross assets · filed 31 Mar 2026
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P.US private fund · Active · Cayman Islands · $625.9M gross assets · filed 31 Mar 2026
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND II, L.P.US private fund · Active · Cayman Islands · $480.6M gross assets · filed 31 Mar 2026
DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V, L.P.US private fund · Active · Cayman Islands · $449.3M gross assets · filed 31 Mar 2026
DECHENG CAPITAL GLOBAL HEALTHCARE FUND (MASTER), LPUS private fund · Active · Cayman Islands · $228.2M gross assets · filed 31 Mar 2026
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND I, L.P.US private fund · Active · Cayman Islands · $78.9M gross assets · filed 31 Mar 2026
DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V-A, L.P.US private fund · Active · Cayman Islands · $32.9M gross assets · filed 31 Mar 2026
DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V-B, L.P.US private fund · Active · Cayman Islands · $22M gross assets · filed 31 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Decheng Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Decheng Capital joined

Round sizes, Decheng Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

3SBioAadiAccuragenACELYRINAdaptive BiotechnologiesAdelaAK MedicalAlbireo PharmaAlpine Immune SciencesAnHeart Therapeuticsand 62 more

Portfolio and exits

Every company Decheng Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Decheng Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Decheng Capital

Events where Decheng Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Decheng Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

31 Mar 2026Fund filingForm ADV filed by DC GLOBAL VENTURES: 8 private funds, $2.7B in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Decheng Capital is based in Menlo Park, United States. It also has an office in Shanghai.

In 2012.

8 fund vehicles are on public registers (SEC adviser filings), including DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P., DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P. and DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND II, L.P.

Stages: Early stage, Growth. Sectors: Life sciences. From the firm’s own website.

Decheng Capital lists 72 portfolio companies on its website, including 3SBio, Aadi, Accuragen, ACELYRIN and Adaptive Biotechnologies.

Firms whose websites list some of the same companies include Foresite Capital, Biomatics Capital and Longitude Capital.

Know before Decheng Capital’s next round is announced.

PRO tracks Decheng Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Decheng CapitalGet Decheng Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.